Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

IMM Investment

Investor type Micro VC

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 56
Average round size
info
The average size of a deal this fund participated in
$61M
Portfolio companies 42
Rounds per year 2.33
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Exits 4
Key employees 4

Areas of investment

  • Marketplace
  • E-Commerce
  • Artificial Intelligence
  • Mobile Apps
  • Machine Learning
Summary

The venture was found in Asia in South Korea. The main department of described VC is located in the Seoul.

We can highlight the next thriving fund investment areas, such as Restaurants, Apps. Among the various public portfolio startups of the fund, we may underline Woowa Brothers, True Balance, Baedal Minjeok For fund there is a match between the country of its foundation and the country of its the most frequent investments - South Korea. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little.

We also calculated 4 valuable employees in our database.

When the investment is from IMM Investment the average startup value is more than 1 billion dollars. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2019.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the IMM Investment, startups are often financed by Capstone Partners Co., Ltd., Bon Angels Venture Partners, Altos Ventures. The meaningful sponsors for the fund in investment in the same round are Altos Ventures, Stonebridge Capital, Smilegate Investment. In the next rounds fund is usually obtained by Altos Ventures, IBK Capital, Goldman Sachs.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of IMM Investment:
Typical Co-investors
IMM Investment is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after IMM Investment:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
CardinalStone Capital Advisers Lagos, Lagos, Nigeria
Central Texas Angel Network Austin, Texas, United States
Cornerstone OnDemand California, Santa Monica, United States
DIMENSION Chiyoda, Japan
EXA Ventures -
Hairong High Tech -
Inspired Evolution Investment Management Gauteng, NA - South Africa, South Africa
Natural Products Canada Canada, Charlottetown, Prince Edward Island
Trellas Enterprises Cyprus, Nicosia

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Shiftup

Gamification
Information Technology
Online Games
Video Games
10 Jul 2022 Seocho, Seoul-t'ukpyolsi, South Korea

Pure Harvest Smart Farms

Agriculture
AgTech
Farming
Fruit
$180M29 Jun 2022 Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates

Rebellions.ai

Artificial Intelligence
Machine Learning
Semiconductor
Software
$53M03 Jun 2022 Seoul, Seoul-t'ukpyolsi, South Korea

O-House

E-Commerce
Home Improvement
Home Services
Interior Design
Lifestyle
Marketplace
Mobile Apps
$182M09 May 2022 South Korea, Gyeonggi-do, South Korea

Neubility

Information Technology
Robotics
$21M27 Apr 2022 South Korea, Gyeonggi-do, South Korea

ENCINA

Chemical
Industrial
Renewable Energy
Waste Management
$55M14 Mar 2022 The Woodlands, Texas, United States

Nearthlab

Artificial Intelligence
Autonomous Vehicles
Drones
Image Recognition
Information Services
Information Technology
Machine Learning
$15M01 Mar 2022 South Korea, Gyeonggi-do, South Korea

BIORCHESTRA

Biopharma
Health Care
Medical
Therapeutics
$45M22 Feb 2022 South Korea, Gangwon-do, South Korea

Retailo Technologies

B2B
E-Commerce
Marketplace
Retail
$7M01 Feb 2022 Saudi Arabia, Riyadh Region, Saudi Arabia
News
GenEdit Announces Series A Financing and Provides Research Update at TIDES 2021

– GenEdit has closed a $26m Series A financing.
– New investors include Eli Lilly, KTB Network, Company K Partners, Korea Investment Partners, DAYLI Partners, KB Investment, IMM Investment, and TIMEFOLIO Asset Management.
– The funding will support the further development of GenEdit’s NanoGalaxy™ platform of non-viral, non-lipid polymer nanoparticles, and the selection for clinical development of therapeutic candidates targeting diseases of the nervous system.

Orum Therapeutics Closes $84 Million Series B Financing to Advance Novel Targeted Protein Degrader Payloads into Clinical Trials for Cancer

– Orum Therapeutics closed a $84m Series B financing.
– The financing was led by IMM Investment and joined by new investors (KDB Investment and Atinum, among others) and existing investors (Intervest and KB Investment, among others).
– Orum plans to use the proceeds to advance the Company’s lead therapeutic candidates into clinical trials, explore additional payload chemistries to develop additional payloads that modulate the ubiquitin pathway, and other general corporate purposes.
– The company has developed a new class of ADC payloads, called neoDegraders, to specifically degrade intracellular target proteins within cancer cells via the E3 ubiquitin ligase pathway.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent IMM Investment?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: